These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Avandia, a leading alternative for Rezulin patients, prescribed to more than 700,000 patients. Diabetes Technol Ther; 2000; 2(2):292. PubMed ID: 11469275 [No Abstract] [Full Text] [Related]
10. Actos (pioglitazone HCL) provides a safe, effective alternative for patients formerly taking Rezulin. Diabetes Technol Ther; 2000; 2(2):290-1. PubMed ID: 11469274 [No Abstract] [Full Text] [Related]
11. [Oral therapy in type 2 diabetes. Critical evaluation of glitazones]. Lotz N MMW Fortschr Med; 2002 Jan; 144(3-4):48-50. PubMed ID: 11862793 [No Abstract] [Full Text] [Related]
12. Plaintiff's attorney actively seeking out patients who have used various FDA approved medications and who "may be entitled to compensation for damages caused by these medications". South D J Miss State Med Assoc; 2000 Nov; 41(11):798-9. PubMed ID: 11107716 [No Abstract] [Full Text] [Related]
13. Rezulin pulled in the UK. Zurlinden J Nurs Spectr (Wash D C); 1998 May; 8(9):25. PubMed ID: 10542729 [No Abstract] [Full Text] [Related]
14. Diabetes recall. Though Rezulin's withdrawal is a blow for some patients, there are ways to cope. Here's how. Gorman C Time; 2000 Apr; 155(13):94. PubMed ID: 11009709 [No Abstract] [Full Text] [Related]
15. New labeling and use changes for Rezulin. Klonoff DC Diabetes Technol Ther; 1999; 1(3):350. PubMed ID: 11484719 [No Abstract] [Full Text] [Related]
16. Rezulin to be withdrawn from the market. Diabetes Technol Ther; 2000; 2(2):289. PubMed ID: 11469272 [No Abstract] [Full Text] [Related]